The Eurasian Journal of Medicine
Review
Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome

Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome

1.

Department of Nutrition and Dietetics, Sivas Cumhuriyet University School of Health Sciences, Sivas, Turkey

2.

Department of Nutrition and Dietetics, Erciyes University School of Health Sciences, Kayseri, Turkey

Eurasian J Med 2019; 51: 280-284
DOI: 10.5152/eurasianjmed.2019.18420
Read: 255 Downloads: 35 Published: 15 October 2019

Metabolic syndrome is associated with a group of conditions abdominal obesity, high triglyceride levels, reduction in low-density lipoprotein, increased blood pressure, and increased fasting blood glucose. Hence, it poses a risk for type 2 diabetes and cardiovascular diseases. The prevalence of metabolic syndrome increases with age. Nesfatin-1, which affects different systems, has recently been discovered as a regulatory peptide molecule. With the discovery of nesfatin-1, it has been reported to inhibit the intake of nutrients and have significant regulatory effects on energy metabolism. As nesfatin-1 is present in both central and peripheral tissues, it is thought to have many functions. In addition to its suppressive effect on food intake, nesfatin-1 has also been reported to have an effect on the blood glucose level for regulating cardiac functions and affecting obesity by providing weight loss. Considering the effects of nesfatin-1, it may be associated with metabolic syndrome.

 

Cite this article as: Tekin T, Çiçek B, Konyalıgil N. Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome. Eurasian J Med 2019; 51(3): 280-4.

Files
ISSN1308-8734 EISSN 1308-8742